Fig. 3From: Efficacy and safety of cinacalcet compared with other treatments for secondary hyperparathyroidism in patients with chronic kidney disease or end-stage renal disease: a meta-analysisEffect of cinacalcet versus control treatment in patients with chronic kidney disease. A) Serum parathyroid hormone; B) Serum calcium; C) Serum phosphate; D) Calcium phosphorus productBack to article page